AstraZeneca pays SEC US$5.5 million after 10-year FCPA investigation
US Securities and Exchange Commission
UK-based pharmaceutical company AstraZeneca will pay US$5.5 million to resolve charges it violated the Foreign Corrupt Practices Act, while the Justice Department has closed its investigation into the matter.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10